Effect of food on a new drug in healthy volunteers
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study looks at how taking the study drug PA-111 with food changes how it is absorbed and how safe it is in healthy people. It helps researchers understand the best way to take the medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 19 years of age or older.
- You must be a healthy volunteer.
- You must weigh at least 50 kg (about 110 pounds) if you are male, or at least 45 kg (about 99 pounds) if you are female.
- Your body mass index (BMI) must be between 18.0 and 30.0.
- You must not have taken part in another clinical trial with an investigational drug within the past 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how two study drugs, PA-111 and PA-111A, are processed by the body and how safe they are. Healthy volunteers are needed to compare the two drugs.
This study will compare two versions of a drug (called AD-117 and AD-117A) to see how your body processes them and whether they are safe. You would receive one version and then the other, to compare their effects.
This study tests a new investigational drug (DA-5222) in healthy volunteers to see how food affects its absorption. It helps determine the best way to take the medication.
This trial tests two experimental drugs in healthy adults to see how they interact with each other and to check their safety. It involves taking the drugs in a specific order over multiple days.
This study tests a new medicine called AD-231 and compares it to taking three separate pills together. You would need to be in generally good health and within a certain age and weight range.
This trial tests two forms of a new medicine to see how safe they are and how the body handles them. It is for healthy adults aged 19 to 64, and participation helps gather important early information before the drug is studied in patients.
Hear when a new Mixed Dyslipidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.